A Comparative Analysis of Pharmacovigilance Practices in Urban and Rural Healthcare Settings

The problem of ADR is worldwide. Higher rates of morbidity and mortality could result from ADRs. Adverse drug reactions lead to unnecessary financial costs. As treatments become increasingly complex, robust pharmacovigilance systems are needed to guarantee the safe use of pharmaceuticals in all healthcare settings. In India, 1% ADR is reported. Globally, it is an average of 5-10%, which is much higher than India. The ineffective ADR monitoring system, insufficient pharmacovigilance, and ADR knowledge, attitudes and behaviours are mostly to blame for this. Pharmacovigilance, which monitors and assesses adverse drug reactions (ADRs), is crucial to guaranteeing the safety and efficacy of pharmaceuticals to examine healthcare workers' pharmacovigilance knowledge, attitudes, and behaviours in both rural and urban healthcare institutions.In terms of variations in reporting methods, infrastructure, the active involvement of healthcare professionals, and awareness levels, this study examines the pharmacovigilance procedures in urban and rural healthcare settings. Data was collected by structured questionnaires, interviews, and a review of the pharmacovigilance records of a select group of urban and rural health care settings. According to the results, pharmacovigilance systems in cities tend to be more technologically sophisticated and well-organized, with more experienced staff members and greater reporting rates of adverse drug reactions.Conversely, rural regions may face limited resources, inadequate training, and a lack of awareness among patients and healthcare professionals. The study highlights the necessity of focused interventions, such as better education, awareness campaigns, and infrastructure support, to improve rural pharmacovigilance procedures. This gap needs to be filled to increase patient safety and deliver equitable healthcare outcomes across different geographic regions.